Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
0.5597
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.5597
Bid (Size)
0.5500 (14)
Ask (Size)
0.5800 (7)
Prev. Close
0.5597
Today's Range
0.5597 - 0.5597
52wk Range
0.5597 - 19.90
Shares Outstanding
4,063,081
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 10, 2024
Via
Benzinga
Why Biora Therapeutics (BIOR) Stock Is Down 45%
December 10, 2024
Biora Therapeutics shares are trading lower by 45% during Tuesday's session. The company announced that it will be delisted from Nasdaq.
Via
Benzinga
Performance
YTD
-95.79%
-95.79%
1 Month
-67.08%
-67.08%
3 Month
-90.28%
-90.28%
6 Month
-91.72%
-91.72%
1 Year
-95.66%
-95.66%
More News
Read More
Dow Falls 150 Points; Oracle Posts Downbeat Results
December 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 14, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics's Earnings Outlook
November 13, 2024
Via
Benzinga
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
November 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 29, 2024
Via
Benzinga
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 29, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
October 28, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
October 14, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 08, 2024
Via
Benzinga
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
October 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
September 30, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Achieves ISO 13485 Certification
September 09, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Positive Nasdaq Listing Decision
August 28, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
August 12, 2024
Via
InvestorPlace
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Funding Agreement with Existing Investors
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
August 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
July 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
July 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.